CorMedix Inc
SWB:19KA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CorMedix Inc
SWB:19KA
|
US |
|
A
|
AES Corp
LSE:0H6G
|
US |
|
Sotera Health Co
NASDAQ:SHC
|
US |
|
N
|
Nov Inc
F:NO8
|
US |
|
V
|
Visteon Corp
SWB:VS51
|
US |
|
K
|
Keysight Technologies Inc
F:1KT
|
US |
|
N
|
Nucor Corp
F:NUO
|
US |
Wall St Price Targets
19KA Price Targets Summary
CorMedix Inc
According to Wall Street analysts, the average 1-year price target for 19KA is 13.459 EUR with a low forecast of 11.299 EUR and a high forecast of 17.168 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 19KA's stock price target?
Price Target
13.459
EUR
According to Wall Street analysts, the average 1-year price target for 19KA is 13.459 EUR with a low forecast of 11.299 EUR and a high forecast of 17.168 EUR.
What is the Revenue forecast for CorMedix Inc?
Projected CAGR
8%
The compound annual growth rate for Revenue over the next 8 years is 8%.
What is the Gross Profit forecast for CorMedix Inc?
Projected CAGR
8%
The compound annual growth rate for Gross Profit over the next 5 years is 8%.
What is the Operating Income forecast for CorMedix Inc?
Projected CAGR
6%
The compound annual growth rate for Operating Income over the next 8 years is 6%.
What is the Pre-Tax Income forecast for CorMedix Inc?
Projected CAGR
-28%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -28%.
What is the Net Income forecast for CorMedix Inc?
Projected CAGR
-36%
The compound annual growth rate for Net Income over the next 3 years is -36%.
